Skip to content

Motivational Interviewing (MI) to Reduce Khat Use

Evaluation of Motivational Interviewing (MI) to Reduce Khat Use Among Somali Refugees in Kenya

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02253589
Acronym
MIkhat
Enrollment
200
Registered
2014-10-01
Start date
2014-10-31
Completion date
2015-12-31
Last updated
2017-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Khat Use Disorder

Brief summary

Healthy khat user with the intention to reduce or stop khat use will be randomly assigned to a one-session brief intervention or waiting list. Reductions in khat use will be measured from pre- to post-assessment which will be one month apart. After one month, the waiting list will receive the same intervention.

Detailed description

The leaves of the khat tree are traditionally chewed in some African and Arab countries. They contain the mild central stimulant cathinone. In recent years, the production, trade and use has dramatically increased and excessive patterns of use as well as a specific dependence syndrome have been described. So far, no experiences exist in psychological treatment of khat addiction. In this study, we use a brief motivational intervention based on the WHO's ASSIST-linked Brief Intervention and Motivational Interviewing to support users who have the intention to reduce or stop their khat use. Khat users will be recruited in the community. Trained local staff will assess participant's khat and other substance use at study entry and one month later. Users will be assigned randomly to intervention or waiting list control groups. The intervention group will receive a single 20-minute brief intervention. The waiting list will receive the same intervention after the second assessment. After two months, a final assessment will be made in both groups.

Interventions

BEHAVIORALmodified ASSIST-linked Brief Intervention

Trained counsellors support participant's motivation to reduce or stop khat use in a 20 minute counselling session.

Sponsors

Africa Institute of Mental and Brain Health (AFRIMEB)
CollaboratorOTHER
University of Konstanz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy individuals

Exclusion criteria

Severe psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Time-Line-Follow-Back: Self-reported days with khat use and amount of khat useone monthParticipants report in a calender for each day of the past month whether they used khat and how much of it.

Secondary

MeasureTime frameDescription
Time-Line-Follow-Back: other substance useOne monthParticipants report for each day of the past month whether they used other substances of abuse, i.e. alcohol, illegal drugs

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026